奥拉帕尼
医学
PARP抑制剂
内科学
肿瘤科
卵巢癌
癌症
聚ADP核糖聚合酶
遗传学
生物
聚合酶
基因
作者
Éric Pujade-Lauraine,Frédèric Selle,Giovanni Scambia,Bernard Asselain,Frederik Marmé,Kristina Lindemann,Nicoletta Colombo,Radosław Mądry,Rosalind Glasspool,Ignace Vergote,Jacob Korach,S. Lheureux,Coraline Dubot,Ana Oaknin,Claudio Zamagni,Florian Heitz,Laurence Gladieff,María Jesús Rubio-Pérez,Paolo Scollo,Christopher Blakeley
标识
DOI：10.1016/j.annonc.2023.09.3110
摘要
Poly(ADP-ribose) polymerase (PARP) inhibitor maintenance therapy is the standard of care for some patients with advanced ovarian cancer. We evaluated the efficacy and safety of PARP inhibitor rechallenge.
科研通智能强力驱动
Strongly Powered by AbleSci AI
高大凌寒
剑指东方是为谁
非而者厚
VDC
核桃
MchemG
遇上就这样吧
斯寜
Gummybear
竹筏过海
淡然的舞仙
andrele
Li
Qin
YifanWang
kento
小海
星辰坠于海
pcr163
陈炫铭
皖公网安备34019202002308
